300,000
Clinical Trial Records
60,000
Product/Candidates
50,000
Sponsor/Organisation
December 06,2022 05:19 AM
CCI Approves Bharat Biotech International Eastman Exports Deal
December 06,2022 05:17 AM
Pfizer Applies For FDA Authorization For Omicron-retooled Vaccine Booster In Kids Under 5
December 05,2022 05:05 AM
Solid Biosciences Announces Stockholder Approval Of Acquisition Of AavantiBio
December 05,2022 04:56 AM
US FDA Approves Rigel Pharma Rezlidhia To Treat Relapsed Or Refractory AML
December 05,2022 04:54 AM
WuXi STA Launches New Parenteral Formulation Manufacturing Line
December 06,2022 05:12 AM
ImmuneOncia Announces Phase 2 Results Of PD-L1 Immune Checkpoint Inhibitor At ESMO Asia
December 06,2022 05:07 AM
Lynk Pharmaceuticals Announces First Patient Dosed In Phase Ⅱ Clinical Study Of LNK01003 In Patients With Ulcerative Colitis
December 06,2022 04:56 AM
Innovent And UNION Therapeutics Announce First Subject Dosed In A Chinese Clinical Phase I Study Of The Novel PDE4 Inhibitor Orismilast (IBI353)
December 06,2022 04:51 AM
Novartis Phase III PSMAfore Study Of Pluvicto A PSMA Targeted Radioligand Therapy Meets Primary Endpoint
December 01,2022 05:30 AM
Eisai And Biogen Announced The Results From Large Global Phase 3 Confirmatory Clarity AD Clinical Study Of Lecanemab
December 01,2022 04:50 AM
US FDA Grants Fast Track Designation To Kintara Therapeutics REM-001 To Treat Cutaneous Metastatic Breast Cancer
November 21,2022 04:42 AM
Iveric Bio Announces FDA Has Granted Breakthrough Therapy Designation For Avacincaptad Pegol For Geographic Atrophy
November 15,2022 05:18 AM
Akesos Ivonescimab PD-1/VEGF Bispecific Antibody, AK112 Granted Breakthrough Therapy Designation For I-O Resistance NSCLC Patients In China
November 15,2022 05:12 AM
US FDA Grants Orphan Drug Designation To Avstera’s AVS100 To Treat Advanced Stage Melanoma
November 11,2022 05:10 AM
US FDA Grants Fast Track Designation To Immunomic Therapeutics PDNA Vaccine, ITI-3000 To Treat Merkel Cell Carcinoma
December 06,2022 04:54 AM
Immunocore And Gadeta Announce Agreement To Develop First Gamma Delta (γδ) TCR ImmTAC For Solid Tumors
December 05,2022 05:37 AM
Incyte And CMS Announce Collaboration And License Agreement For Ruxolitinib Cream In Greater China And Southeast Asia
December 05,2022 04:58 AM
WHO And EU Renew Partnership For Universal Health Coverage
November 29,2022 05:18 AM
XtalPi CK Life Sciences Collaborate To Jointly Develop AI-empowered Tumour Vaccine R&D Platform
November 29,2022 05:14 AM
C4XD Inks Worldwide Licensing Pact With AstraZeneca Worth Up To $402 Mn To Develop & Commercialise NRF2 Activator Programme
Clinical trials data Insight in all Regulated Market, which includes and not limited to US, EU, AUS & NZ, Japan, Canada & India.
Clinical trials data Insight on over 3,00,000 clinical trials from Phase 0 to IV across all indication includes, Orphan disease and Therapy Area.
Sponsor key contacts on over 50,000 companies along with its category as Large, Mid and Small companies for identifying licensing candidates.
Clinical trial data coverage of over 60,000 Molecules of all Regulated Markets.
Pipeline Analysis of Company.
Key Information to help CRO for Outsourcing Projects.
Molecules categorised as Biologics Vs. Small Molecules to hit the right target for Licensing candidates.
News Alerts on Deals, In-Licensing, Out-licensing, Clinical Trial Development of molecules, Safety and efficacy data.
Orphan drug designation insights on all candidates
Fast track & Breakthrough designation by regulatory body.
